However, these screening methodologies are unable to identify the molecular typing of HCC and preoperative tumor grade; AFP’s sensitivity in screening of HCC is very limited as increased level of AFP has been reported in many other liver diseases as well [4, 5]. The gene discussed is AFP; the disease is hepatocellular carcinoma.